Assyro AI

FDA Orange Book · active-ingredient family

Estrogens, conjugated synthetic a

Estrogens, conjugated synthetic a is approved in 2 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.

Reference-listed drug:CENESTIN · NDA 020992

2

Brand (NDA)

0

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · cream, tablet

ProductApplicantApplicationTEApproved
CENESTINRLD×5ASPENNDA 020992Jun 21, 2002
SYNTHETIC CONJUGATED ESTROGENS ATEVA WOMENSNDA 021788Nov 28, 2008

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Estrogens, conjugated synthetic a — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.